Characterization of Ca2+-inhibited potassium channels in the LNCaP human prostate cancer cell line

Receptors and Channels

Volumn 6, Issue 4, 1999, Pages 241-253

  Skryma, Roman ^a   Van Coppenolle, Fabien ^a   Dufy Barbe, Luce ^b   Dufy, Bernard ^b   Prevarskaya, Natalia ^a  

^a Université des Sciences et Technologies de Lille   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Intracellular Ca2+; K+ channels; LNCaP cells; Patch clamp

Indexed keywords

CALCIUM ION; DENDROTOXIN; MAST CELL DEGRANULATING PEPTIDE; POTASSIUM CHANNEL; POTASSIUM ION; TETRYLAMMONIUM;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; MEMBRANE CURRENT; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL;

ADENOCARCINOMA; CALCIUM; CHARYBDOTOXIN; ELAPID VENOMS; HUMANS; ION CHANNEL GATING; ION TRANSPORT; LYMPHATIC METASTASIS; MALE; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; PROSTATIC NEOPLASMS; QUINIDINE; TETRAETHYLAMMONIUM; TUMOR CELLS, CULTURED;

EID: 0032777630     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bregestovski P Redkozubov A and Alexcev A (1986) Nature 319 776-778.
2. Carstens RP Eaton JV Krigman HR Walther PJ and Garcia-Blanco MA (1997) Oncogene 3059-3065.
3. Chung I and Schlichter LC (1997) Am J Physiol 273 (Cell Physiol 42) C622-C633.
4. Decoursey TE Chandy KG Gupta S and Cahalan MD (1987) J Gen Physiol 89 379-404.
5. Douglass J Osborne PB Cai YC Wilkinson M Christie MJ and Adelman JP (1990) J Immunol 144 4841-4850.
6. Dubois JM and Rouzaire-Dubois B (1993) Prog Biophys Molec Biol 59 1-21.
7. Fedida D Wible B Wang Z Fermini B Faust F Nattel S and Brown AM (1993) Circ Res 73 210-216.
8. Franklin RB Zou J Gorski E Yang YH and Costello LC (1997) Mol Cell Endocrinol 127(1) 19-25.
9. Furuya Y Lin XS Walsh JC Nelson WG and Isaacs JT (1995) Endocrinology 136 1898-1906.
10. Garcia ML Honner M Knaus HG Koch R Schmalhofer W Slaughter RS and Kaczorowski GJ (1997) Adv Pharmacol 39 425-471.
11. Grissmer S Lewis RS and Cahalan D (1992) J Gen Physiol 99 63-84.
12. Grissmer S Nguyen AN Aiyar JA Hanson DC Mather RJ Gutman GA Karmilowicz MJ Auperin DD and Chandy KG (1994) Pharmacol 45 1227-1234.
13. Heurteaux C and Lasdunski M (1991) Brain Res 554 22-29.
14. Hille B (1992) Sinauer Associates Inc., Sunderland, MA, 2nd ed.
15. Horoszewicz JS Leong SS Kawinski E Karr JP Rosenthal H Chu MT Mirand MT and Murphy GP (1983) Cancer Res 43 1908-19182.
16. Janssen T Darro F Petein M Raviv G Pasteels JL Kiss R and Schulman CC (1996) Cancer 77 144-149.
17. Lang DG and Ritchie AL (1990) J Physiol (Lond) 45 117-132.
18. Lepple-Wienhues A Berweck S Böhmig M Leo CP Meyling B Garbe C and Wiederholt M (1996) J Membrane Biol 151 149-157.
19. Limonta P Dondi D Moretti RM Maggi R and Motta M (1992) J Clin Endocrinol Metab 75 207-212.
20. Lovisolo D Distasi C Antoniotti S and Munaron L (1997) New Physiol Sci 12 279-285.
21. MacKinnon R and Yellen G (1990) Science 250 276-279.
22. Nilius B and Wohlrab W (1992) J Physiol (Lond) 445 537-548.
23. Nilius B and Droogmans G (1994) News Physiol Sci 9 105-110.
24. Nörenberg W Gebicke-Haerter PJ and Illes P (1994) J Physiol (Lond) 475 15-32.
25. Pancrazio JJ Tabbara JA and Kim YJ (1993) Anticancer Res 13 1231-1234.
26. Penner R Petersen M Pierau FK and Dreyer F (1986) Pflügers Arch 407 365-369.
27. Peppelenbosch MP Tertoolen LGJ Den Hertog J and De Laat SW (1992) Cell 69 295-303.
28. Pongs O (1992) Physiol Rev 72(4) S69-S88.
29. Prevarskaya N Skryma R Vacher P Bresson-Bepoldin L Odessa MF Rivel J San Galli F Guerin J and Dufy-Barbe L (1994) Mol and Cell Neurosci 5 699-708.
30. Prevarskaya NB Skryma RN Vacher P Daniel N Djiane J and Dufy B (1995) The J Biol Chem 270(41) 24292-24299.
31. Sherwood ER Van Dongen JL Wood CG Liao S Kozlowski JM and Lee C (1998) Brit J Cancer 77(6) 855-861.
32. Schlichter LC Pahapill PA and Schumacher PA (1993) Receptor Channel 1 201-215.
33. Schreiber M Wei A Yuan A Gaut J Saito M and Salkoff L (1998) The J Biol Chem 273(6) 3509-3516.
34. Skryma R Prevarskaya N Vacher P and Dufy B (1994) Am J Physiol 267 C544-C553.
35. Skryma R Prevarskaya N Dufy-Barbe L Odessa MF Audin J and Dufy B (1997) Prostate 32 N4 112-122.
36. Solano RM Carmena MJ Carrero I Cavallaro S Roman F Hueso C Travali S Lopez-Fraile N Guijarro G and Prieto JC (1996) Endocrinology 137(7) 2815-2822.
37. Stansfeld CE Roper J Ludwig J Weseloh RM Marsh SJ Brown DA and Pongs O (1996) PNAS 93 9910-9914.
38. Stühmer W Ruppersberg JP Schröter KH Sakmann B Stocker M Giese KP Perschke A Baumann A and Pongs O (1989) Embo J 8 3235-3244.
39. Wang SY Castle NA and Wang GK (1992) Glia 5 146-153.
40. Weller H Bernhardt U Siemen D Dreyer F Vogel W and Habermann E (1985) N-S Arch Pharmacol 330 77-83.
41. Wonderlin WF and Strobl JS (1996) J Membrane Biol 154 91-107.
42. Yu SP Yeh CH Sensi SL Gwag BJ Canzoniero LMT Farhangrazi ZS Ying HS Tian M Dugan LL and Choi DW (1997) Science 218 114-117.